A multicentre, retrospective study of transarterial chemoembolization (TACE) with sorafenib in treatment-naive patients with hepatocellular carcinoma (HCC) patients with portal vein tumour thrombus (PVTT)
Latest Information Update: 19 May 2021
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 May 2021 New trial record